Blinding is crucial to ensure that the results of a clinical trial are as unbiased as possible. It prevents the placebo effect, where participants may report improvements in symptoms just because they believe they are receiving a treatment. It also mitigates observer bias, where researchers might unintentionally skew the results to favor the outcome they expect.
